UIC
CDNA icon

Uniplan Investment Counsel’s CareDx CDNA Stock Holding History

Uniplan Investment Counsel’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.48M Buy
157,131
+94,358
+150% +$2.05M 0.42% 70
2026
Q1 		$1.09M Buy
62,773
+34,506
+122% +$653K 0.11% 136
2025
Q4 		$533K Buy
+28,267
New +$474K 0.05% 152

Other funds holding CDNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Uniplan Investment Counsel's CDNA Position: Q2 2026 in Review

Uniplan Investment Counsel increased its CareDx (CDNA) stake by 150% in Q2 2026, buying an estimated $2.05M and bringing the position to 157,131 shares worth $4.48M. The position accounts for 0.42% of the portfolio, ranked #70.

Uniplan Investment Counsel first reported a position in CDNA in Q4 2025 and has held it in 3 quarters since. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Uniplan Investment Counsel held 157,131 shares of CareDx worth $4.48M as of Q2 2026.
  • Uniplan Investment Counsel bought 94,358 CareDx shares in Q2 2026, an estimated $2.05M.
  • CareDx made up 0.42% of Uniplan Investment Counsel's portfolio in Q2 2026, its #70 holding.
  • Uniplan Investment Counsel first reported a position in CareDx in Q4 2025 and has held it in 3 quarters since.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Uniplan Investment Counsel's 13F filing for Q2 2026, filed 13 Aug 2026.